GB0121151A
GB0121151D0
(en)
|
2001-08-31 |
2001-08-31 |
Anti-cancer compounds
|
US10/487,871
US7297701B2
(en)
|
2001-08-31 |
2002-08-30 |
Anti-cancer cyclopenta [G]quinazoline compounds
|
EP10177988A
EP2332962A1
(en)
|
2001-08-31 |
2002-08-30 |
Cyclopenta[g]quinazoline compounds for use in the treatment of inflammatory or allergic conditions
|
CA2458813A
CA2458813C
(en)
|
2001-08-31 |
2002-08-30 |
Anti-cancer cyclopenta[g]quinazoline compounds
|
EP02755281A
EP1421105B1
(en)
|
2001-08-31 |
2002-08-30 |
Anti-cancer cyclopenta¬g quinazoline compounds
|
JP2003525018A
JP4328202B2
(en)
|
2001-08-31 |
2002-08-30 |
Anti-cancer cyclopenta [G] quinazoline compound
|
PT02755267T
PT1420809E
(en)
|
2001-08-31 |
2002-08-30 |
Use of cyclopenta[g]quinazoline derivatives for treating cancer
|
PCT/GB2002/003961
WO2003020300A1
(en)
|
2001-08-31 |
2002-08-30 |
Use of cyclopenta[g]quinazoline derivatives for treating cancer
|
DK02755281.9T
DK1421105T3
(en)
|
2001-08-31 |
2002-08-30 |
Anti-cancer cyclopenta [g] quinazoline compounds
|
US10/487,874
US7528141B2
(en)
|
2001-08-31 |
2002-08-30 |
Use of cyclopenta[g]quinazoline derivatives for treating cancer
|
PCT/GB2002/003979
WO2003020748A1
(en)
|
2001-08-31 |
2002-08-30 |
Anti-cancer cyclopenta[g]quinazoline compounds
|
KR1020107007266A
KR20100043294A
(en)
|
2001-08-31 |
2002-08-30 |
Anti-cancer cyclopenta[g]quinazoline compounds
|
KR1020047002994A
KR100983962B1
(en)
|
2001-08-31 |
2002-08-30 |
Anti-cancer cyclopenta[g]quinazoline compounds
|
AT02755281T
ATE483722T1
(en)
|
2001-08-31 |
2002-08-30 |
ANTI-CANCER CYCLOPENTAAG CHINAZOLINE DERIVATIVES
|
EP02755267A
EP1420809B1
(en)
|
2001-08-31 |
2002-08-30 |
Use of cyclopenta[g]quinazoline derivatives for treating cancer
|
EP10185923A
EP2311850A1
(en)
|
2001-08-31 |
2002-08-30 |
Anti-cancer cyclopenta[g]quinazoline compounds
|
BRPI0212215A
BRPI0212215B8
(en)
|
2001-08-31 |
2002-08-30 |
cyclopenta[g]quinazoline anticancer compounds, use thereof for the treatment of cancer and pharmaceutical composition comprising said compound
|
AT02755267T
ATE526028T1
(en)
|
2001-08-31 |
2002-08-30 |
USE OF CYCLOPENTAÄGÜCHINAZOLINE DERIVATIVES FOR CANCER TREATMENT
|
ES02755267T
ES2373644T3
(en)
|
2001-08-31 |
2002-08-30 |
USE OF CYCLOPENTA DERIVATIVES [G] QUINAZOLINE FOR THE TREATMENT OF C�? NCER.
|
MXPA04001905A
MXPA04001905A
(en)
|
2001-08-31 |
2002-08-30 |
Anti-cancer cyclopenta[g]quinazoline compounds.
|
AU2002321576A
AU2002321576B2
(en)
|
2001-08-31 |
2002-08-30 |
Anti-cancer cyclopenta[G]quinazoline compounds
|
DK02755267.8T
DK1420809T3
(en)
|
2001-08-31 |
2002-08-30 |
Use of cyclopenta [G] quinazoline derivatives for the treatment of cancer
|
PT02755281T
PT1421105E
(en)
|
2001-08-31 |
2002-08-30 |
Anti-cancer cyclopenta¬g quinazoline compounds
|
DE60237902T
DE60237902D1
(en)
|
2001-08-31 |
2002-08-30 |
ANTIQUE CYCLOPENTAiG CHINAZOLINE DERIVATIVES
|
ZA2004/01587A
ZA200401587B
(en)
|
2001-08-31 |
2004-02-26 |
Anti-cancer cyclopenta[g]quinazoline compounds
|
US11/710,985
US7863284B2
(en)
|
2001-08-31 |
2007-02-27 |
Anti-cancer cyclopenta[G]quinazoline compounds
|
US11/727,242
US7705006B2
(en)
|
2001-08-31 |
2007-03-26 |
Anti-cancer cyclopenta[g]quinazoline compounds
|
US12/588,910
US8486955B2
(en)
|
2001-08-31 |
2009-11-02 |
Anti-cancer cyclopenta [g] quinazoline compounds
|
US12/659,286
US8063056B2
(en)
|
2001-08-31 |
2010-03-03 |
Anti-cancer cyclopenta [g]quinazonline compounds
|
US12/801,853
US8552016B2
(en)
|
2001-08-31 |
2010-06-29 |
Anti-cancer cyclopenta(g)quinazoline compounds
|
CY20111100015T
CY1111078T1
(en)
|
2001-08-31 |
2011-01-04 |
ANTI-CANCER COMPOUNDS [G] KINAZOLIN
|
CY20111101237T
CY1112143T1
(en)
|
2001-08-31 |
2011-12-13 |
USE OF KYKLOPENTA [G] KINAZOLIN PRODUCTS FOR CANCER TREATMENT
|